CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Acetaminophen PM

430R WALGREENS Acetaminophen 500 mg,Diphenhydramine HCl 25 mg Tablet· ingredient acetaminophenAminoalkyl ethers· ACETAMINOPHEN 500 mg/1; DIPHENHYDRAMINE 25 mg/1; ACETAMINOPHEN 500 mg/1; DIPHENHYDRAMINE HCL 25 mg/1; ACETAMINOPHEN 500 mg/1; DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.04537
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other acetaminophen products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
Acetaminophen Oral Solution$0.01218−$0.03320
Basic Care Daytime Cold and Flu$0.01348−$0.03190
24-7 Life BY 7-ELEVEN Nighttime Cold and Flu$0.01504−$0.03030
Acetaminophen Extra Strength$0.01901−$0.02640
ADWE Childrens Pain Fever$0.02109−$0.02430
basic care tussin cf severe$0.02410−$0.02130
Acetaminophen 325mg$0.02520−$0.02020
365 whole foods market acetaminophen$0.03423−$0.01110

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.